| Date |
Title |
Rating |
| 2010-11-30 |
Opinions: Obama's Global Fund pledge; harm reduction in Iran; HIV prevention; African development |
None |
| 2010-11-30 |
Jiangsu Yanshen found liable for producing and selling inferior quality products |
None |
| 2010-11-30 |
Resverlogix files new patent for dosing combinations of RVX-208, statin therapeutics |
None |
| 2010-11-30 |
DTRA presents Outstanding Scientific Achievement award to Aduro BioTech |
None |
| 2010-11-30 |
Dongsheng enters agreement to acquire micro-emulsion alprostadil injection from Wan'Te |
None |
| 2010-11-30 |
APP to launch Topotecan for Injection following FDA marketing approval |
None |
| 2010-11-30 |
University of Adelaide researcher leads collaboration for universal flu vaccine |
None |
| 2010-11-30 |
Case Western Reserve University grants Thermalin Diabetes exclusive license on portfolio of insulin analogs |
None |
| 2010-11-30 |
Alza files patent infringement suit against Impax in connection with Concerta |
None |
| 2010-11-29 |
FDA approves Axiron topical solution CIII for testosterone replacement therapy in men |
None |
| 2010-11-29 |
WomanCare Global expands product portfolio to include Roselle, Optinor |
5 |
| 2010-11-29 |
Synthon receives FDA final approval for generic Xyzal |
1 |
| 2010-11-29 |
Perrigo launches generic Aleve Liquid Gels |
None |
| 2010-11-29 |
USPTO awards Immunitor key patent for viral vaccine |
None |
| 2010-11-29 |
Common, overprescribed drugs lead to election dopiness and immaturity |
None |
| 2010-11-29 |
Spectrum's FUSILEV sNDA accepted by FDA for review |
None |
| 2010-11-29 |
3SBio acquires pegsiticase global rights from EnzymeRx for $6.25 million |
None |
| 2010-11-29 |
AMAG updates product label of Feraheme Injection |
None |
| 2010-11-29 |
NovaBay announces meeting with FDA to discuss Aganocide compound for impetigo |
None |
| 2010-11-29 |
Accentia enters strategic agreement with Baxter to purchase Cytoxan drug |
None |
| 2010-11-29 |
Affymax, Takeda to regulate peginesatide drug for treating anemia in CRF patients |
None |
| 2010-11-29 |
HAL Allergy files MAA for PURETHAL Mites and SUBLIVAC FIX products at Paul-Ehrlich-Institute |
None |
| 2010-11-29 |
Marcus evans Summit highlights potential growth, innovation in drug discovery |
None |
| 2010-11-29 |
Selcia announces drug discovery collaboration agreement with Gilead Sciences |
None |
| 2010-11-29 |
Pfizer, Protalix announce marketing authorization submission in Europe for taliglucerase alfa |
None |
| 2010-11-28 |
New irreversible covalent approach to inhibit viral protease |
None |
| 2010-11-28 |
GFS solution to Cholera |
None |
| 2010-11-28 |
Pharma enhances its focus on Asia-Pacific partnerships |
None |
| 2010-11-26 |
Impax initiates patent challenge in connection with SIMCOR |
None |
| 2010-11-26 |
Researchers synthesize iron compounds that inhibit growth of Mycobacterium tuberculosis |
None |
| 2010-11-26 |
FDA extends review period of Cladribine Tablets for MS therapy |
None |
| 2010-11-25 |
Personalized oncology requires new paradigm for drug development, experts say |
None |
| 2010-11-25 |
Looking back and moving forward: 100 years of Pneumococcal vaccination |
None |
| 2010-11-25 |
Use of aspirin and statins can reduce depression: Study |
4.3 |
| 2010-11-25 |
Further studies needed over use of Proton-Pump Inhibitors in early pregnancy |
None |
| 2010-11-25 |
Researchers explain molecular mechanism that induces HER2+ tumours to ignore cell signals |
None |
| 2010-11-25 |
Genzyme meets FDA consent decree by ending fill/finish activities in Allston plant |
None |
| 2010-11-25 |
Specialists suggest U.S. should stockpile cholera vaccines for rapid deployment at disease outbreak |
None |
| 2010-11-25 |
RCSI review highlights development in drug discovery field |
None |
| 2010-11-24 |
E. coli host bacterium produces antibiotic erythromycin A |
None |
| 2010-11-24 |
Breastfeeding while taking epilepsy drugs may not affect child's IQ |
None |
| 2010-11-24 |
Researchers find IGF1 topical gel can treat sudden sensorineural hearing loss |
5 |
| 2010-11-24 |
Diabetes drug may counteract against Alzheimer's disease: Research |
None |
| 2010-11-24 |
USFDA grants Sun Pharma tentative marketing approval for generic Cymbalta |
None |
| 2010-11-24 |
A new treatment landscape for triple-negative breast cancer |
None |
| 2010-11-24 |
FDA warning leads to decrease in antidepressant prescribing for young patients |
None |
| 2010-11-24 |
Ziconotide could promote suicidal tendencies in vulnerable patients: Research |
None |
| 2010-11-24 |
Researchers find link between acrolein and multiple sclerosis |
None |
| 2010-11-24 |
Meningitis immunization program to launch in 3 African countries next month |
None |
| 2010-11-24 |
Daily oral antiretroviral reduces HIV infection risk in MSM by 44%, study finds |
None |
| 2010-11-23 |
Gilead submits Truvada/TMC278 single-tablet regimen NDA to FDA |
3 |
| 2010-11-23 |
Vertex submits NDA for telaprevir for treating hepatitis C |
3 |
| 2010-11-23 |
Radical change to Alzheimer’s management |
None |
| 2010-11-23 |
UnitedHealthcare introduces Pharmacy Saver program to provide affordable prescription drugs |
None |
| 2010-11-23 |
Ziconotide could promote suicidal tendencies: Study |
5 |
| 2010-11-23 |
Genzyme issues Award of Excellence to Shanghai ChemPartner |
None |
| 2010-11-23 |
AADA releases updated position statement on isotretinoin usage |
None |
| 2010-11-23 |
HIV drugs lead to insulin resistance |
None |
| 2010-11-23 |
USPTO issues patent for neurotherapeutic pharmaceutical formulation |
None |
| 2010-11-22 |
Par enters distribution agreement with AstraZeneca for generic Accolate |
None |
| 2010-11-22 |
Soligenix receives U.S patent for modified immunogen in RiVax vaccine |
None |
| 2010-11-22 |
Confidisc introduces new anti-illegal drug syringe |
None |
| 2010-11-22 |
Is the decade long flirtation with vaccines over? |
None |
| 2010-11-22 |
Impax initiates challenge of patents relating to WELCHOL |
None |
| 2010-11-22 |
FDA grants Impax tentative approval for generic Cymbalta NDA |
None |
| 2010-11-22 |
Grifols launches Flebogamma 10% DIF intravenous immune globulin in the U.S. |
None |
| 2010-11-22 |
Spectral enters distribution agreement with Toray to market TORAYMYXIN in Canada |
None |
| 2010-11-22 |
Convergence enters drug discovery collaboration with Selcia for chronic pain treatment |
None |
| 2010-11-20 |
Best Practices study: Mock review helps effective approach for preparing team for NDA advisory committee meeting |
None |
| 2010-11-20 |
Surveyed cardiologists, PCPs perceive Crestor comparable to Lipitor in ability to reduce mortality |
None |
| 2010-11-20 |
Vical to present results of Vaxfectin adjuvant at Conference in Hungary |
None |
| 2010-11-20 |
Xanodyne to withdraw propoxyphene-containing products from the U.S. market |
None |
| 2010-11-20 |
Quercetin in Gene-Eden may be beneficial against flu virus: Research |
None |
| 2010-11-20 |
Appeals Court stays judgment in Marine Polymer's patent infringement case against HemCon |
None |
| 2010-11-20 |
Psychiatric hospitalization rate decreases among adults with schizophrenia treated with INVEGA SUSTENNA: Study |
5 |
| 2010-11-20 |
Vigor-25 contains hidden drug ingredient, warns FDA |
None |
| 2010-11-20 |
NEXTERONE Premixed Injection uses CyDex Captisol technology platform |
None |
| 2010-11-20 |
Xanodyne Pharmaceuticals decides to voluntarily remove propoxyphene from the U.S. market |
None |
| 2010-11-20 |
NexACT technology improves oral delivery of five small molecule drugs |
None |
| 2010-11-20 |
Merck wins third FOSAMAX bellwether trial |
1 |
| 2010-11-20 |
FDA-approved anti-parasite drug blocks Wnt signaling pathway in colon cancer |
None |
| 2010-11-20 |
Antares advances VIBEX QS platform for highly-viscous drug injection |
None |
| 2010-11-19 |
Xgeva receives FDA approval for prevention of SREs in patients with bone metastases |
None |
| 2010-11-19 |
Cough suppressant syrup may predict patients metabolise tamoxifen in breast cancer treatment |
None |
| 2010-11-19 |
Personalised medicine could help develop effective treatments for serious diseases |
None |
| 2010-11-19 |
Doctors recommend drug holidays from bisphosphonates to enhance bone health |
None |
| 2010-11-19 |
Jeffrey Bethune files lawsuit against Bristol-Myers Squibb for denying overtime pay |
None |
| 2010-11-19 |
National monitoring essential for preventing emergence of malaria drug resistance |
None |
| 2010-11-19 |
Advanced Life Sciences submits application to FDA for ALS-886 to treat ARDS |
5 |
| 2010-11-19 |
Ethicon submits BLA to FDA for Fibrin Pad |
None |
| 2010-11-19 |
FDA approves IDE application for Home Hemodialysis system |
4 |
| 2010-11-19 |
FDA approves new drug application for NEXTERONE Premixed Injection |
None |
| 2010-11-19 |
Expert panel to endorse newly approved therapeutic vaccine for advanced prostate cancer |
None |
| 2010-11-19 |
New findings show promising treatment for MS |
3 |
| 2010-11-19 |
Eisai signs statement of intent with WHO to supply medicine for treatment of lymphatic filariasis |
None |
| 2010-11-18 |
Call for more transparency and improvements to drug safety in Canada |
None |
| 2010-11-18 |
Multiple epidemiological parameters drive increase in drug-treatment opportunities for pancreatic cancer: Decision Resources |
None |
| 2010-11-18 |
PAREXEL reaches milestone in early phase studies |
None |
| 2010-11-18 |
CDC data: Adults remain unvaccinated against preventable infectious illnesses |
None |
| 2010-11-18 |
Multiple sclerosis drug shows promise to counteract effects of botulinum neurotoxin |
None |
| 2010-11-18 |
FIP's PSWC and AAPS Annual Meeting to highlight targeted inhalable dry powder HPV vaccine |
None |
| 2010-11-18 |
Sun Pharma receives FDA approval for generic Tiazac ANDA |
None |
| 2010-11-18 |
New anti-cancer drug targeting vitamin D receptor reduces PSA level in HRPC |
5 |
| 2010-11-18 |
FDA approves Sun Pharma's generic Clarinex ANDA |
None |
| 2010-11-18 |
EMA reviews CTI's Pixuvri Marketing Authorization Application for NHL |
None |
| 2010-11-18 |
Merck announces FDA Advisory Committee approval of GARDASIL for anal cancer and AIN treatment |
None |
| 2010-11-18 |
Statins activate bacterial-killing properties of white blood cells |
None |
| 2010-11-18 |
FDA grants three years of marketing exclusivity to ISTA's BROMDAY |
None |
| 2010-11-17 |
New pharmacogenetic test enables a personalized medicine approach |
None |
| 2010-11-17 |
Cancer patients can still access NICE rejected drugs |
None |
| 2010-11-17 |
Cholesterol-lowering statin therapy benefits patients with calcium buildup in arteries |
None |
| 2010-11-17 |
Vical enters agreement with GenomIdea to develop DNA vaccine for pandemic influenza |
None |
| 2010-11-17 |
New dressing materials and plasters indicate pathological changes in the skin |
None |
| 2010-11-17 |
New technique to purify propolis |
None |
| 2010-11-17 |
LFA encouraged by FDA Advisory Committee vote on BENLYSTA for autoimmune disease lupus |
None |
| 2010-11-17 |
Warfarin taken along with herbal, dietary supplements may be dangerous |
None |
| 2010-11-17 |
TexanPlus HMO provides affordable access to cholesterol-lowering prescription drugs |
None |
| 2010-11-17 |
NYU Langone creates new pharmacy with advanced robotic equipment |
None |
| 2010-11-17 |
Targeted therapies could treat a broad range of cancers: Research |
None |
| 2010-11-17 |
Canada recognizes Nov. 18 as Antibiotic Awareness Day |
None |
| 2010-11-17 |
LRI pleased with FDA Advisory Committee's approval of Benlysta for lupus |
None |
| 2010-11-17 |
New inhalable dry powder antibiotic may reduce TB treatment time |
None |
| 2010-11-17 |
FDA Arthritis Advisory Committee recommends approval of BENLYSTA for SLE |
None |
| 2010-11-17 |
Eisai enters strategic drug discovery collaboration with FORMA Therapeutics |
None |
| 2010-11-17 |
FDA partners with CDC to kick off Get Smart about Antibiotics Week |
None |
| 2010-11-17 |
Type 2 diabetes market in Mexico to grow to $1.22 billion in 2014: Report |
None |
| 2010-11-16 |
Optivia, UCSF receive SBIR grant to develop transporter-based assay system |
None |
| 2010-11-16 |
UCSF, Pfizer announce partnership to accelerate translation of biomedical research |
None |
| 2010-11-16 |
Yukon receives grant under QTDP program for SmartMix delivery platform |
None |
| 2010-11-16 |
FDA grants Impax final approval for generic Allegra-D ANDA |
None |
| 2010-11-16 |
Patrys announces capital raising of $3.2 million and share purchase plan |
None |
| 2010-11-16 |
Can Pfizer rescue hormonal replacement therapy? |
None |
| 2010-11-16 |
Color of tablet appears to be integral component for OTC product |
None |
| 2010-11-16 |
Study shows asthma drugs can treat aortic aneurysm |
5 |
| 2010-11-16 |
Orexo's Abstral sales increases 345% to £14.1m |
None |
| 2010-11-16 |
New mechanism breaks drug resistance in ovarian cancer |
None |
| 2010-11-16 |
FDA announces program to facilitate development of external defibrillators to treat abnormal heart rhythms |
None |
| 2010-11-16 |
Hospira launches two-gram vial of gemcitabine hydrochloride for injection |
None |
| 2010-11-16 |
District Court judgment favors Otsuka in Abilify patent litigation |
5 |
| 2010-11-16 |
Study finds two-thirds of asthma patients take combined ICS/LABA treatment |
None |
| 2010-11-16 |
National campaign to highlight significance of antibiotic resistance |
None |
| 2010-11-16 |
Researchers develop new vaccine delivery system for rotavirus infection |
5 |
| 2010-11-16 |
New inhalable dry powder treatment for lung cancer shows significant increase in survival rates: Research |
None |
| 2010-11-16 |
Fisetin slows onset of motor problems, delays death in three models of Huntington's disease: Study |
None |
| 2010-11-16 |
FDA approves Halaven therapy for metastatic late-stage breast cancer |
None |
| 2010-11-16 |
RBC boosting drugs may undermine breast cancer treatment with Herceptin |
None |
| 2010-11-16 |
Health Canada approves Apricus's Vitaros for erectile dysfunction |
5 |
| 2010-11-16 |
NPR reports on dengue vaccine progress |
None |
| 2010-11-15 |
Sangart's MP4CO receives orphan drug designation for acute pain in sickle cell disease |
None |
| 2010-11-15 |
Cyplasin selects Aurobindo Pharma to supply API component for Ribavirin drug |
None |
| 2010-11-15 |
Emerging blood thinners to prevent stroke |
None |
| 2010-11-15 |
Shire announces FDA approval of Vyvanse Capsules CII for ADHD in adolescents |
3 |
| 2010-11-15 |
Best ways for proper disposal of unused medicines |
5 |
| 2010-11-15 |
Research on P450 compound I may help eliminate toxins |
None |
| 2010-11-15 |
Santarus announces commercial U.S. launch of CYCLOSET for type 2 diabetes mellitus |
None |
| 2010-11-15 |
Researchers find influenza vaccines can contain allergenic components |
None |
| 2010-11-15 |
Dalton Pharma enters co-operation with Lonza to provide integrated chemistry services |
None |
| 2010-11-15 |
AMP receives FDA approval to manufacture ophthalmic product using Capmatic Patriot dropper bottle filling line |
None |
| 2010-11-15 |
Study finds children more likely to be allergic to amoxicillin |
None |
| 2010-11-15 |
Oregon scientist investigates safety, effectiveness of novel low-cost family-planning option |
None |
| 2010-11-15 |
Report documents increase in R&D projects on developing world diseases |
None |
| 2010-11-15 |
Drug industry: Pharmaceutical companies find ways to cope as patents expire; FDA criticized for consulting contracts |
None |
| 2010-11-15 |
Labopharm receives notice about Activis' ANDA for OLEPTRO |
None |
| 2010-11-14 |
Acne, acne medicine and mental health: Study |
None |
| 2010-11-12 |
Neurologix third quarter net loss decreases to $2.3 million |
None |
| 2010-11-12 |
Labopharm receives notice of Activis' ANDA submission for generic OLEPTRO |
None |
| 2010-11-12 |
VIMOVO granted marketing and pricing approval in the UK |
None |
| 2010-11-12 |
Dreaded cod liver oil in a variety of flavours |
None |
| 2010-11-12 |
Drug industry roundup: Fosamax trial focuses scrutiny on osteoporosis drugs; What about $4 generics; Recalls undermining confidence |
None |
| 2010-11-12 |
Urgent action needed to prevent and treat childhood pneumonia |
None |
| 2010-11-12 |
Ordway, Milestone to develop drug formulation for administration through CompuFlo injection technology |
None |
| 2010-11-12 |
Carter Center, Merck take steps to prevent river blindness in Latin America |
None |
| 2010-11-12 |
Oligomerix receives SBIR Phase II grant to develop drugs for Alzheimer’s disease |
None |
| 2010-11-12 |
Forest enters commercialization collaboration with Janssen for Bystolic and Savella in Canada |
None |
| 2010-11-12 |
Diabetic drug may retard growth of fluid-filled cysts in PKD: Research |
None |
| 2010-11-12 |
Aeras receives grant to develop new vaccines for TB |
None |
| 2010-11-12 |
COMP issues positive opinion for Celsion's ThermoDox Orphan Drug Designation |
None |
| 2010-11-12 |
Nature News examines meningitis vaccine program to roll out in Africa |
None |
| 2010-11-11 |
FDA grants SEDASYS System appeal |
None |
| 2010-11-11 |
Meda acquires Pyralvex, Spasmonal and Waxsol from Norgine |
None |
| 2010-11-11 |
FDA identifies promising steps to enhance safety of CT scans |
None |
| 2010-11-11 |
Most drug and biological product makers meet postmarketing requirements and commitments |
None |
| 2010-11-11 |
Adolor receives U.S. Patent for beloxepin to treat pain |
None |
| 2010-11-11 |
New 'magic bullet' can eradicate side effects of drug used to treat cystinosis |
None |
| 2010-11-11 |
Dendreon requests licensure for additional capacity to manufacture PROVENGE at New Jersey facility |
None |
| 2010-11-11 |
Lemon-lime soft drink could improve effectiveness of oral anticancer drug: Study |
None |
| 2010-11-11 |
PolyMedix receives FDA regulatory clearance for PMX-30063 IND application |
None |
| 2010-11-10 |
Egrifta receives FDA approval for treatment of HIV-lipodystrophy |
None |
| 2010-11-10 |
Appeals court upholds five-year exclusivity period for Shire's VYVANSE |
None |
| 2010-11-10 |
Hemispherx Biopharma awarded grant for Ampligen, Alferon development programs |
5 |
| 2010-11-10 |
PPIs, antiplatelet drugs can help treat CV disease patients at high risk of upper GI bleeding |
None |
| 2010-11-10 |
Omeros identifies orphan GPCR compound that potentiates tumor-killing activity of doxorubicin |
None |
| 2010-11-10 |
Covidien analysis finds lower incidence of GI adverse events with topical NSAIDs versus oral |
None |
| 2010-11-10 |
Women taking HPV vaccine need only two HPV screening tests for rest of their lives: Research |
None |
| 2010-11-10 |
Breast cancer patients more likely to have joint pain from taking AIs: Study |
None |
| 2010-11-10 |
Lower-protein infant formula helps attain same growth rate as breastfed infants |
None |
| 2010-11-10 |
Using mild painkillers during pregnancy can increase risk of male reproductive disorders |
None |
| 2010-11-10 |
Malaria drug artesunate found more effective than quinine at preventing severe falciparum malaria deaths in children, study says |
3 |
| 2010-11-10 |
Clot-busting drug remains the most beneficial emergency treatment for strokes |
None |
| 2010-11-10 |
Flu vaccination programs can protect employee health, save businesses money |
None |
| 2010-11-10 |
Restylane boosts people's first impression |
5 |
| 2010-11-10 |
Aromatase inhibitors increase side effects in women undergoing breast cancer therapy |
2 |
| 2010-11-10 |
TONIX Pharmaceuticals announces Phase 2a study results of cyclobenzaprine in Fibromyalgia Syndrome |
None |
| 2010-11-10 |
Orexo third quarter net revenues decrease to MSEK 35.9 |
None |
| 2010-11-10 |
Health reform policy: Flexible spending, device taxes and waivers |
None |
| 2010-11-10 |
Federal appellate court rules in favor of Merck in TEMODAR patent infringement suit |
None |
| 2010-11-09 |
Baxa launches ExactaMix 1200 Automated Compounding Device |
None |
| 2010-11-09 |
Semafore's SF1126 for B-cell chronic lymphocytic leukemia granted FDA orphan drug designation |
None |
| 2010-11-09 |
Provectus holds second meeting with Australian TGA to review approval of PV-10 for metastatic melanoma |
None |
| 2010-11-09 |
Research report on current and evolving technologies in drug delivery |
None |
| 2010-11-09 |
EUSA completes BLA filing for ERWINASE in treatment of acute lymphoblastic leukemia |
None |
| 2010-11-09 |
Ultrasound needle guidance improves performance and outcomes of knee injections |
None |
| 2010-11-09 |
Fake antimalarial medications uncovered across Ghana |
None |
| 2010-11-09 |
Intercell aggregate revenues decrease 28.4% to EUR 21.1m in 9 months ended September 30, 2010 |
None |
| 2010-11-09 |
Combination treatment with methotrexate and prednisone achieves remission in newly-developed RA |
None |
| 2010-11-09 |
Scientists develop nanobioconjugate drug to target brain tumor |
None |
| 2010-11-09 |
Cook Medical's controlled-release esophageal stent receives FDA clearance |
1 |
| 2010-11-09 |
EpiCept third quarter net loss decreases to $3.2 million |
None |
| 2010-11-09 |
Epeius receives competitive grant to support Rexin-G oncology product |
None |
| 2010-11-09 |
CMS to review cancer vaccine, analysis shows high Medicare drug spending not correlated with better care |
None |
| 2010-11-09 |
Advaxis collaborates with UBC to develop live attenuated Listeria vaccines |
None |
| 2010-11-09 |
Teens abuse prescription drugs more than illegal drugs |
None |
| 2010-11-08 |
Study finds anti-gout medication may reduce risk of colorectal cancer |
None |
| 2010-11-08 |
Gents renews distribution agreement for AcnEase with Herborium |
None |
| 2010-11-08 |
Tadalafil improves Raynaud's phenomenon symptoms in people with scleroderma |
None |
| 2010-11-08 |
Blocking beta glucuronidase enzyme could eliminate side effects of CPT-11 in colon cancer treatment |
None |
| 2010-11-08 |
Vapor rub improves sleep for children with cold symptoms |
None |
| 2010-11-08 |
Apricus receives $733,437 grants under QTDP program |
None |
| 2010-11-08 |
Hydroxychloroquine may reduce cardiac neonatal lupus in subsequent pregnancies: Research |
None |
| 2010-11-08 |
Statin drugs do not benefit pediatric lupus patients |
None |
| 2010-11-08 |
Amgen wins Scrip Best New Drug award for Prolia |
5 |
| 2010-11-08 |
GeoVax receives $244,500 grant under QTDP program for HIV/AIDS vaccine development |
None |
| 2010-11-08 |
Clinical Data receives $500,000 grants under QTDP program |
None |
| 2010-11-08 |
FDA approves Cymbalta for treatment of chronic musculoskeletal pain |
None |
| 2010-11-08 |
FDA reviews GSK's response to Complete Response letter for Horizant |
None |
| 2010-11-08 |
Leaders discuss best practices, challenges for detecting counterfeit medications |
None |
| 2010-11-08 |
Report: FDA conflict-of-interest rules too restrictive |
None |
| 2010-11-08 |
New malaria drug can save millions of lives: Study |
None |
| 2010-11-07 |
APP Drug Hotline to assist healthcare professionals with shortage issues |
None |
| 2010-11-07 |
FDA issues approval letter to Carestream's CR system for mammography |
None |
| 2010-11-05 |
Melanoma drug breakthrough |
5 |
| 2010-11-04 |
CaPre drug candidate effective in managing impaired glucose tolerance |
None |
| 2010-11-04 |
EUSA Pharma announces 10-year outcome data of PROSTASCINT in prostate cancer radiotherapy |
None |
| 2010-11-04 |
Patient share of Actemra for RA to exceed patient share for Cimzia and Simponi, says Report |
None |
| 2010-11-04 |
HPV vaccine enjoys wide support from medical and public health communities |
None |
| 2010-11-04 |
Nanotherapeutics receives contract from DOD to support clinical trial for treating dehisced surgical wounds |
None |
| 2010-11-04 |
FIP Annual Meeting to improve global health through advances in pharmaceutical sciences |
None |
| 2010-11-04 |
Champions Biotechnology receives $1.46 million in grants under QTDP program |
None |
| 2010-11-04 |
Cardium receives $245,000 grant under QTDP program |
None |
| 2010-11-04 |
Spectrum Pharmaceuticals receives $977,900 grant under QTDP program |
None |
| 2010-11-04 |
Acton submits Manufacturing Supplement to FDA for AEROSPAN Inhalation Aerosol |
None |
| 2010-11-04 |
Pharma in Asia-Pacific region becomes more active in R&D, study finds |
None |
| 2010-11-03 |
ADVENTRX submits NDA for Exelbine to FDA |
None |
| 2010-11-03 |
Questcor announces launch of H.P. Acthar Gel for infantile spasms |
None |
| 2010-11-03 |
Lundbeck A/S third quarter revenue increases 7% to DKK 3,619 million |
None |
| 2010-11-03 |
EUREKA program confirms ability of HIFU technology to deliver cancer drugs |
None |
| 2010-11-03 |
Scientists recommend research on bacterial vaccine to prevent influenza |
None |
| 2010-11-03 |
OMJPI enters agreement with Watson to distribute generic version of CONCERTA tablets |
None |
| 2010-11-03 |
CONRAD receives $5 million award from USAID |
None |
| 2010-11-03 |
Somaxon awarded $245,000 grant for Silenor under QTDP program |
None |
| 2010-11-03 |
FDA grants Cadence marketing approval for OFIRMEV injection in management of pain and fever |
None |
| 2010-11-03 |
UK watchdog agency to lose power to reject new drugs |
None |
| 2010-11-03 |
Huber's Health & Nutrition business receives approval to produce active pharmaceutical ingredients |
None |
| 2010-11-03 |
Inviragen receives two grants to develop dengue and chikungunya vaccines |
None |
| 2010-11-03 |
Talecris announces launch of PROLASTIN-C in Canada |
None |
| 2010-11-02 |
GSK's Revolade receives Japanese approval for treatment of chronic ITP |
1 |
| 2010-11-02 |
Watson enters exclusive agreement with OMJPI to market authorized generic Concerta |
None |
| 2010-11-02 |
FDLI issues first e-Advance article on Food and Drug Law Journal |
None |
| 2010-11-02 |
VaxInnate’s prototype flu vaccine named as Top 10 Infectious Diseases Projects to Watch in 2011 |
None |
| 2010-11-02 |
New targeted therapy shows positive results in patients with lung cancer |
None |
| 2010-11-02 |
NSAIDs drugs prevent colon cancer: Research |
None |
| 2010-11-02 |
Teva third quarter net sales increase 20% to $4.3 billion |
None |
| 2010-11-02 |
Impax initiates litigation against Shire over supply of generic Adderall XR |
None |
| 2010-11-02 |
FDA announces partnership agreement with University of Rochester to form ACTION Initiative |
None |
| 2010-11-02 |
Study finds inhaled corticosteroids increase type 2 diabetes risk |
None |
| 2010-11-02 |
Study finds increasing dosage of blood thinners can help cardiovascular disease patients with genetic defect |
None |
| 2010-11-02 |
Boehringer Ingelheim announces availability of PRADAXA in U.S. pharmacies |
None |
| 2010-11-02 |
Access Pharmaceuticals receives $1.5 million in government grants |
None |
| 2010-11-01 |
NICE to lose its power to ban life saving drugs |
None |
| 2010-11-01 |
Valeant, Kadmon enter strategic agreement for taribavirin and ribavirin |
None |
| 2010-11-01 |
FDA approves cancer drug Afinitor for treatment of rare genetic disorder |
None |
| 2010-11-01 |
Short courses of antibiotics have long-term impact on microbial flora of human gut |
None |
| 2010-11-01 |
GlobalData releases new pipeline assessment and market forecasts report on peripheral arterial disease |
None |
| 2010-11-01 |
FDA grants orphan drug designation to Discovery's KL4 surfactant for CF treatment |
None |
| 2010-11-01 |
Spectrum submits complete response to FDA's CRL for FUSILEV to treat colorectal cancer |
None |
| 2010-11-01 |
BetterRxCard helps McLennan County residents save on prescription drugs |
None |
| 2010-11-01 |
Biodel receives FDA CRL for Linjeta NDA |
None |
| 2010-11-01 |
Acorda reports net income of $12.4 million for third quarter 2010 |
None |
| 2010-11-01 |
Cell Therapeutics announces submission of MAA to European Medicines Agency for Pixuvri |
None |
| 2010-11-01 |
FDA approves Afinitor drug for tuberous sclerosis complex |
None |